- Home
- LYEL vs ENX Comparison
LYEL vs ENX Comparison
Compare LYEL & ENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LYEL
- ENX
- Stock Information
- Founded
- LYEL 2018
- ENX 2002
- Country
- LYEL United States
- ENX United States
- Employees
- LYEL N/A
- ENX N/A
- Industry
- LYEL Biotechnology: Pharmaceutical Preparations
- ENX Finance/Investors Services
- Sector
- LYEL Health Care
- ENX Finance
- Exchange
- LYEL Nasdaq
- ENX Nasdaq
- Market Cap
- LYEL 207.7M
- ENX 167.6M
- IPO Year
- LYEL 2021
- ENX N/A
- Fundamental
- Price
- LYEL $7.99
- ENX $9.14
- Analyst Decision
- LYEL Sell
- ENX
- Analyst Count
- LYEL 2
- ENX 0
- Target Price
- LYEL $1.00
- ENX N/A
- AVG Volume (30 Days)
- LYEL 52.5K
- ENX 25.4K
- Earning Date
- LYEL 05-13-2025
- ENX 01-01-0001
- Dividend Yield
- LYEL N/A
- ENX 3.94%
- EPS Growth
- LYEL N/A
- ENX N/A
- EPS
- LYEL N/A
- ENX 0.16
- Revenue
- LYEL $65,000.00
- ENX N/A
- Revenue This Year
- LYEL N/A
- ENX N/A
- Revenue Next Year
- LYEL N/A
- ENX N/A
- P/E Ratio
- LYEL N/A
- ENX $61.00
- Revenue Growth
- LYEL N/A
- ENX N/A
- 52 Week Low
- LYEL $7.65
- ENX $7.84
- 52 Week High
- LYEL $56.00
- ENX $10.07
- Technical
- Relative Strength Index (RSI)
- LYEL 42.95
- ENX 36.79
- Support Level
- LYEL $7.65
- ENX $9.18
- Resistance Level
- LYEL $10.30
- ENX $9.34
- Average True Range (ATR)
- LYEL 0.75
- ENX 0.12
- MACD
- LYEL 0.06
- ENX -0.02
- Stochastic Oscillator
- LYEL 12.83
- ENX 4.88
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.
About ENX Eaton Vance New York Municipal Bond Fund of Beneficial Interest $.01 par value
Eaton Vance New York Municipal Bond Fund is principally engaged in managing investment funds and providing investment management and advisory services to high-net-worth individuals and institutions. It is a non-diversified, closed-end investment company. Its objective is to provide current income exempt from regular federal income tax, including alternative minimum tax, and, in state specific funds, taxes in specified state.